{
    "0DL.F": {
        "short_name": "BIOSYNEX INH.  EO-,10",
        "long_name": "Biosynex SA",
        "summary": "Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. It offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as instruments. The company also provides self-tests; self-measurement products, including thermometers and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper-and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "France",
        "state": null,
        "city": "Illkirch-Graffenstaden",
        "zipcode": "67400",
        "website": "http://www.biosynex.com",
        "market_cap": "Micro Cap"
    },
    "ALBIO.PA": {
        "short_name": "BIOSYNEX",
        "long_name": "Biosynex SA",
        "summary": "Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. It offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as instruments. The company also provides self-tests; self-measurement products, including thermometers and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper-and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Illkirch-Graffenstaden",
        "zipcode": "67400",
        "website": "http://www.biosynex.com",
        "market_cap": "Micro Cap"
    },
    "ALERS.PA": {
        "short_name": "EUROBIO-SCIENTIFIC",
        "long_name": "Eurobio Scientific Soci\u00e9t\u00e9 anonyme",
        "summary": "Eurobio Scientific Soci\u00c3\u00a9t\u00c3\u00a9 anonyme discovers and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Soci\u00c3\u00a9t\u00c3\u00a9 anonyme in June 2018. Eurobio Scientific Soci\u00c3\u00a9t\u00c3\u00a9 anonyme was founded in 1997 and is headquartered in Les Ulis, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Les Ulis",
        "zipcode": "91953",
        "website": "http://www.diaxonhit.com",
        "market_cap": "Micro Cap"
    },
    "ALMDT.PA": {
        "short_name": "MEDIANTECHNOLOGIES",
        "long_name": "Median Technologies SA",
        "summary": "Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiopsy (Imaging BIOmarker Phenotyping System), a phenomics imaging platform empower translational research with AI powered Biomarker identification tools and inform clinical decisions using CT scan similarity search for patient profiling services; and iSee for image analysis and management in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California San Diego to conduct a study for its proprietary imaging platform iBiopsy validation. The company was founded in 2002 and is based in Valbonne, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Valbonne",
        "zipcode": "06560",
        "website": "http://www.mediantechnologies.com",
        "market_cap": "Micro Cap"
    },
    "ALPRE.PA": {
        "short_name": "PREDILIFE",
        "long_name": "Predilife S.A.",
        "summary": "Predilife S.A. develops and sells medical techniques and mathematical models. The company provides genetic testing, medical imaging, etc. Its product, MammoRisk, is a test for predicting the development of breast cancer based on the patient's individual risk. The company has a partnership agreement with Institut Curie for genetic analyses for MammoRisk. Predilife S.A. was founded in 2004 and is based in Villejuif, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Villejuif",
        "zipcode": "94800",
        "website": "http://www.predilife.com",
        "market_cap": "Nano Cap"
    },
    "BIM.PA": {
        "short_name": "BIOMERIEUX",
        "long_name": "bioM\u00e9rieux S.A.",
        "summary": "bioM\u00c3\u00a9rieux S.A. develops and produces in vitro diagnostic solutions for private and hospital laboratories for the diagnosis of infectious diseases. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. The company was formerly known as B-D M\u00c3\u00a9rieux. bioM\u00c3\u00a9rieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioM\u00c3\u00a9rieux S.A. is a subsidiary of Institut M\u00c3\u00a9rieux SA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Marcy l'\u00c3\u0089toile",
        "zipcode": "69280",
        "website": "http://www.biomerieux.com",
        "market_cap": "Large Cap"
    },
    "BIM.VI": {
        "short_name": "BIOMERIEUX",
        "long_name": "bioM\u00e9rieux S.A.",
        "summary": "bioM\u00c3\u00a9rieux S.A. develops and produces in vitro diagnostic solutions for private and hospital laboratories for the diagnosis of infectious diseases. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. The company was formerly known as B-D M\u00c3\u00a9rieux. bioM\u00c3\u00a9rieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioM\u00c3\u00a9rieux S.A. is a subsidiary of Institut M\u00c3\u00a9rieux SA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "VIE",
        "market": "at_market",
        "country": "France",
        "state": null,
        "city": "Marcy l'\u00c3\u0089toile",
        "zipcode": "69280",
        "website": "http://www.biomerieux.com",
        "market_cap": "Large Cap"
    },
    "BMXMF": {
        "short_name": "BIOMERIEUX",
        "long_name": "bioM\u00e9rieux S.A.",
        "summary": "bioM\u00c3\u00a9rieux S.A. develops and produces in vitro diagnostic solutions for private and hospital laboratories for the diagnosis of infectious diseases. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. The company was formerly known as B-D M\u00c3\u00a9rieux. bioM\u00c3\u00a9rieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioM\u00c3\u00a9rieux S.A. is a subsidiary of Institut M\u00c3\u00a9rieux SA.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "France",
        "state": null,
        "city": "Marcy l'\u00c3\u0089toile",
        "zipcode": "69280",
        "website": "http://www.biomerieux.com",
        "market_cap": "Large Cap"
    },
    "E8TN.F": {
        "short_name": "EUROBIO SCIEN.INH.EO -,32",
        "long_name": "Eurobio Scientific Soci\u00e9t\u00e9 anonyme",
        "summary": "Eurobio Scientific Soci\u00c3\u00a9t\u00c3\u00a9 anonyme discovers and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Soci\u00c3\u00a9t\u00c3\u00a9 anonyme in June 2018. Eurobio Scientific Soci\u00c3\u00a9t\u00c3\u00a9 anonyme was founded in 1997 and is headquartered in Les Ulis, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "France",
        "state": null,
        "city": "Les Ulis",
        "zipcode": "91953",
        "website": "http://www.diaxonhit.com",
        "market_cap": "Micro Cap"
    },
    "EYWN.F": {
        "short_name": "BIOMERIEUX (P.S.)  O.N.",
        "long_name": "bioM\u00e9rieux S.A.",
        "summary": "bioM\u00c3\u00a9rieux S.A. develops and produces in vitro diagnostic solutions for private and hospital laboratories for the diagnosis of infectious diseases. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. The company was formerly known as B-D M\u00c3\u00a9rieux. bioM\u00c3\u00a9rieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioM\u00c3\u00a9rieux S.A. is a subsidiary of Institut M\u00c3\u00a9rieux SA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "France",
        "state": null,
        "city": "Marcy l'\u00c3\u0089toile",
        "zipcode": "69280",
        "website": "http://www.biomerieux.com",
        "market_cap": "Large Cap"
    },
    "G09.F": {
        "short_name": "GENOMIC VISION S.A. EO-10",
        "long_name": "Genomic Vision Soci\u00e9t\u00e9 Anonyme",
        "summary": "Genomic Vision Soci\u00c3\u00a9t\u00c3\u00a9 Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "France",
        "state": null,
        "city": "Bagneux",
        "zipcode": "92220",
        "website": "http://www.genomicvision.com",
        "market_cap": "Nano Cap"
    },
    "GV.PA": {
        "short_name": "GENOMIC VISION",
        "long_name": "Genomic Vision Soci\u00e9t\u00e9 Anonyme",
        "summary": "Genomic Vision Soci\u00c3\u00a9t\u00c3\u00a9 Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Bagneux",
        "zipcode": "92220",
        "website": "http://www.genomicvision.com",
        "market_cap": "Nano Cap"
    },
    "LBIRD.PA": {
        "short_name": "LUMIBIRD",
        "long_name": "Lumibird SA",
        "summary": "Lumibird SA designs, manufactures, and markets various lasers for the scientific, industrial, and medical markets in France, Europe, the United States, and Asia. It operates in two divisions, Laser and Medical. The Laser division offers products based on fiber laser, solid-state laser, and laser diode technologies for use in industrial, defense, scientific, and medical applications. Its products primarily include solid-state lasers and pulsed laser diodes, fiber lasers and amplifiers, and laser-based electro-optical systems. The Medical division provides diagnostic and treatment equipment for ophthalmology based on lasers and ultrasonic sensors, such as lasers and echographs. The company was founded in 1970 and is based in Lannion, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Lannion",
        "zipcode": "22300",
        "website": "http://www.lumibird.com/en",
        "market_cap": "Small Cap"
    },
    "MLAHC.PA": {
        "short_name": "HEALTH",
        "long_name": "@Health SA",
        "summary": "@Health SA, an e-cardiology company, develops medical devices worldwide. It offers CardioNexion, a medical device for the ultra-early detection and analysis of all cardiovascular pathologies. The company is based in Aix-en-Provence, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Aix-en-Provence",
        "zipcode": "13290",
        "website": "http://www.healthcardionexion.com",
        "market_cap": "Nano Cap"
    }
}